The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
126913141 12691314 1 I 20151229 20160201 20160826 20160826 EXP JP-MALLINCKRODT-T201600387 MALLINCKRODT 76.00 YR F Y 34.00000 KG 20160826 CN JP JP

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
126913141 12691314 1 PS METHADONE METHADONE HYDROCHLORIDE 1 Oral 5 MG (10 MG DAILY DOSE) Y UNKNOWN 40517 TABLET
126913141 12691314 2 SS METHADONE METHADONE HYDROCHLORIDE 1 Oral 5 MG (5 MG DAILY DOSE) Y UNKNOWN 40517 TABLET
126913141 12691314 3 C MORPHINE HCL MORPHINE HYDROCHLORIDE 1 Parenteral 10 MG UNKNOWN 0
126913141 12691314 4 C MORPHINE HCL MORPHINE HYDROCHLORIDE 1 Parenteral 1.5 MG, PRN 0 1.5 MG
126913141 12691314 5 C MORPHINE HCL MORPHINE HYDROCHLORIDE 1 Parenteral 15 MG 0
126913141 12691314 6 C MORPHINE HCL MORPHINE HYDROCHLORIDE 1 Parenteral 8 MG 0
126913141 12691314 7 C MORPHINE HCL MORPHINE HYDROCHLORIDE 1 Parenteral 10 MG 0
126913141 12691314 8 C MORPHINE HCL MORPHINE HYDROCHLORIDE 1 Parenteral 12 MG 0
126913141 12691314 9 C MORPHINE HCL MORPHINE HYDROCHLORIDE 1 Parenteral 14 MG 0
126913141 12691314 10 C MORPHINE HCL MORPHINE HYDROCHLORIDE 1 Parenteral 16 MG 0
126913141 12691314 11 C LINTON HALOPERIDOL 1 Parenteral 0.5 MG UNKNOWN 0
126913141 12691314 12 C TRAVELMIN DIMENHYDRINATE 1 Parenteral 0.2 DF UNKNOWN 0
126913141 12691314 13 C MIDAZOLAM MIDAZOLAMMIDAZOLAM HYDROCHLORIDE 1 Parenteral 2 MG UNKNOWN 0
126913141 12691314 14 C MAGMITT MAGNESIUM OXIDE 1 Oral 990 MG 0
126913141 12691314 15 C CALONAL ACETAMINOPHEN 1 Oral 900 MG UNKNOWN 0
126913141 12691314 16 C LOXOPROFEN LOXOPROFEN 1 Oral 180 MG 0
126913141 12691314 17 C TULOBUTEROL TULOBUTEROL 1 Transdermal 2 MG UNKNOWN 0
126913141 12691314 18 C TRAZODONE HYDROCHLORIDE. TRAZODONE HYDROCHLORIDE 1 Oral 25 MG 0
126913141 12691314 19 C BAKTAR SULFAMETHOXAZOLETRIMETHOPRIM 1 Oral 0.5 DF UNKNOWN 0
126913141 12691314 20 C RINDERON V BETAMETHASONE VALERATE 1 Parenteral 4 MG UNKNOWN 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
126913141 12691314 1 Cancer pain
126913141 12691314 3 Analgesic therapy
126913141 12691314 13 Analgesic therapy
126913141 12691314 20 Analgesic therapy

Outcome of event

Event ID CASEID OUTC COD
126913141 12691314 DE

Reactions reported

Event ID CASEID DRUG REC ACT PT
126913141 12691314 Lung adenocarcinoma
126913141 12691314 Somnolence
126913141 12691314 Vomiting

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
126913141 12691314 1 20151225 20151231 0
126913141 12691314 2 20160101 20160119 0
126913141 12691314 3 20151225 20160107 0
126913141 12691314 4 20151225 0
126913141 12691314 5 20160108 20160110 0
126913141 12691314 6 20160111 20160113 0
126913141 12691314 7 20160114 20160114 0
126913141 12691314 8 20160115 20160117 0
126913141 12691314 9 20160118 20160118 0
126913141 12691314 10 20160119 20160119 0
126913141 12691314 16 20160106 0
126913141 12691314 18 20160106 0